Key Figures
-- Open
0.000 High
0.00 Volume
-- P/E TTM
-- P/E Dynamic
-- Dividend TTM
-- Turnover Ratio
0.018 Prev. Close
0.000 Low
0.00 Turnover
-- P/E Static
-- P/B
0.00% Div Yield TTM
-- ROA
4.740 52wk High
1.51 Volume Ratio
-- Net Profit
-- Shares
-- EPS TTM
0.04 Beta
-- ROE
0.740 52wk Low
32.43% Amplitude
-- Gross Margin
0.00 Market Cap
-0.18 Reward/Risk
39.20% Risk Rate
TradingKey Stock Score No stock score available due to insufficient data.
NLS Pharmaceutics AG News
View more
More news coming soon, stay tuned...
Financial Indicators EPS Relevant data have not been disclosed by the company yet.
Total revenue Relevant data have not been disclosed by the company yet.
NLS Pharmaceutics AG Info NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
Ticker Symbol NLSPW
Company NLS Pharmaceutics AG
CEO Mr. Alexander Zwyer
Website https://nlspharma.com/
FAQs
What is the current price of NLS Pharmaceutics AG (NLSPW)? The current price of NLS Pharmaceutics AG (NLSPW) is 0.02.
What is the symbol of NLS Pharmaceutics AG? The ticker symbol of NLS Pharmaceutics AG is NLSPW.
What is the 52-week high of NLS Pharmaceutics AG? The 52-week high of NLS Pharmaceutics AG is 4.74.
What is the 52-week low of NLS Pharmaceutics AG? The 52-week low of NLS Pharmaceutics AG is 0.74.